A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present ...

Karan Johar's noticeable weight loss has sparked rumours about his possible use of Ozempic, a diabetes drug known for its ...

As the demand for weight loss injectables soars, so too does the market for off-brand alternatives, some of which may not be ...

Dow, S&P 500, and Nasdaq futures are also rising in premarket trading Friday as the stock market looks to end the week in ...

A new study found a link between NovoNordisk’s blockbuster drug Ozempic and a reduced risk of Alzheimer’s disease. 23andMe, ...

Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of ...

Recent research has drawn significant attention to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as Ozempic® ...

Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2 diabetes, ...

Semaglutide, found in Novo Nordisk's Ozempic, may reduce Alzheimer's risk in type 2 diabetes patients, per new research. FDA ...

Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.

A new study is adding to evidence that GLP-1 drugs such as Novo Nordisk's semaglutide and Eli Lilly's tirzepatide could also ...